Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.540
-0.100 (-6.10%)
At close: Feb 21, 2025, 4:00 PM
1.530
-0.010 (-0.65%)
After-hours: Feb 21, 2025, 7:59 PM EST
PACB Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 389.93 | 179.91 | 325.09 | 460.73 | 81.61 | Upgrade
|
Short-Term Investments | - | 454.51 | 447.23 | 583.68 | 237.2 | Upgrade
|
Cash & Short-Term Investments | 389.93 | 634.42 | 772.32 | 1,044 | 318.81 | Upgrade
|
Cash Growth | -38.54% | -17.86% | -26.05% | 227.59% | 549.33% | Upgrade
|
Accounts Receivable | 27.52 | 36.62 | 18.79 | 24.24 | 16.84 | Upgrade
|
Receivables | 27.52 | 36.62 | 18.79 | 24.24 | 16.84 | Upgrade
|
Inventory | 58.76 | 56.68 | 50.38 | 24.6 | 14.23 | Upgrade
|
Prepaid Expenses | 18.78 | 14.04 | 10.29 | 7.39 | 4.87 | Upgrade
|
Restricted Cash | 2.22 | 0.3 | 0.3 | 0.5 | 0.84 | Upgrade
|
Total Current Assets | 497.21 | 742.05 | 852.07 | 1,101 | 355.59 | Upgrade
|
Property, Plant & Equipment | 46.6 | 69.03 | 81.34 | 79.12 | 54.85 | Upgrade
|
Long-Term Investments | - | 12 | - | - | - | Upgrade
|
Goodwill | 313.96 | 462.26 | 409.97 | 409.97 | - | Upgrade
|
Other Intangible Assets | 394.57 | 456.98 | 410.25 | 410.98 | - | Upgrade
|
Other Long-Term Assets | 9.31 | 3.7 | 13.45 | 5.76 | 3.54 | Upgrade
|
Total Assets | 1,262 | 1,746 | 1,767 | 2,007 | 413.98 | Upgrade
|
Accounts Payable | 16.59 | 15.06 | 12.03 | 11 | 3.58 | Upgrade
|
Accrued Expenses | 22.6 | 44.74 | 34.58 | 39.27 | 19.23 | Upgrade
|
Current Portion of Long-Term Debt | - | 0.49 | 1.84 | 1.61 | - | Upgrade
|
Current Portion of Leases | - | 9.59 | 8.89 | 7.71 | 4.33 | Upgrade
|
Current Unearned Revenue | - | 16.34 | 30.5 | 10.98 | 8.72 | Upgrade
|
Other Current Liabilities | - | 8.8 | 175.5 | 1.15 | 2.64 | Upgrade
|
Total Current Liabilities | 39.19 | 95.03 | 263.34 | 71.71 | 38.5 | Upgrade
|
Long-Term Debt | 647.49 | 892.24 | 896.68 | 896.07 | - | Upgrade
|
Long-Term Leases | 24.94 | 31.61 | 41.07 | 49.97 | 37.67 | Upgrade
|
Long-Term Unearned Revenue | 19.76 | 5.53 | 1.79 | 25.05 | 1.57 | Upgrade
|
Other Long-Term Liabilities | 22.47 | 20.3 | 1.3 | 173.19 | 0.75 | Upgrade
|
Total Liabilities | 753.85 | 1,045 | 1,204 | 1,216 | 78.49 | Upgrade
|
Common Stock | 507.79 | 0.27 | 0.23 | 0.22 | 0.19 | Upgrade
|
Additional Paid-In Capital | - | 2,540 | 2,100 | 2,010 | 1,372 | Upgrade
|
Retained Earnings | - | -1,839 | -1,532 | -1,218 | -1,037 | Upgrade
|
Comprehensive Income & Other | - | 0.22 | -4.77 | -1.09 | 0.09 | Upgrade
|
Shareholders' Equity | 507.79 | 701.3 | 562.9 | 790.99 | 335.49 | Upgrade
|
Total Liabilities & Equity | 1,262 | 1,746 | 1,767 | 2,007 | 413.98 | Upgrade
|
Total Debt | 672.43 | 933.93 | 948.48 | 955.36 | 42 | Upgrade
|
Net Cash (Debt) | -282.5 | -299.51 | -176.16 | 89.05 | 276.82 | Upgrade
|
Net Cash Growth | - | - | - | -67.83% | - | Upgrade
|
Net Cash Per Share | -0.98 | -1.18 | -0.78 | 0.44 | 1.58 | Upgrade
|
Filing Date Shares Outstanding | 283 | 267.95 | 247.08 | 221.18 | 193.1 | Upgrade
|
Total Common Shares Outstanding | 283 | 267.74 | 226.51 | 220.98 | 192.29 | Upgrade
|
Working Capital | 458.03 | 647.02 | 588.74 | 1,029 | 317.09 | Upgrade
|
Book Value Per Share | 1.79 | 2.62 | 2.49 | 3.58 | 1.74 | Upgrade
|
Tangible Book Value | -200.74 | -217.94 | -257.32 | -29.97 | 335.49 | Upgrade
|
Tangible Book Value Per Share | -0.71 | -0.81 | -1.14 | -0.14 | 1.74 | Upgrade
|
Machinery | - | 68.03 | 60.86 | 49.8 | 39.78 | Upgrade
|
Construction In Progress | - | 1.34 | 4.7 | 2.3 | 0.14 | Upgrade
|
Leasehold Improvements | - | 35.23 | 34.13 | 31.11 | 29.93 | Upgrade
|
Order Backlog | - | 18.7 | 51.5 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.